News | March 20, 2023
Janssen announces novel dengue antiviral demonstrates efficacy in pre-clinical data
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
Biocorp will receive an initial milestone payment this year
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
The facility has been set up to manufacture tuberculosis testing cartridges
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
Subscribe To Our Newsletter & Stay Updated
